Recurrent Breast Cancer Completed Phase 2 Trials for Cediranib (DB04849)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00244881A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)Treatment